The chromosome 9p21.3 coronary heart disease risk allele is associated with altered gene expression in normal heart and vascular tissues

PLoS ONE

Volumn 7, Issue 6, 2012, Pages

  Pilbrow, Anna P ^a   Folkersen, Lasse ^b   Pearson, John F ^a   Brown, Chris M ^c   McNoe, Les ^c   Wang, Nancy M ^a,b,c,d   Sweet, Wendy E ^d   Tang, W H Wilson ^d   Black, Michael A ^c   Troughton, Richard W ^a   Richards, A Mark ^a   Franco Cereceda, Anders ^b   Gabrielsen, Anders ^b   Eriksson, Per ^b   Moravec, Christine S ^d   Cameron, Vicky A ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b KAROLINSKA INSTITUTE   (Sweden)

^c UNIVERSITY OF OTAGO   (New Zealand)

^d LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; CYCLIN DEPENDENT KINASE INHIBITOR 2B; TRANSCRIPTION FACTOR;

ADULT; AGE DISTRIBUTION; AGED; AORTA; ARTICLE; BINDING SITE; CAROTID ENDARTERECTOMY; CAUSE OF DEATH; CELL CYCLE G1 PHASE; CELL CYCLE PROGRESSION; CHROMOSOME 9P; DOWN REGULATION; ETHNIC DIFFERENCE; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE LOCUS; GENETIC ASSOCIATION; GENETIC MODEL; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HEART DONOR; HEART HYPERTROPHY; HEART INFARCTION; HEART VALVE; HUMAN; HUMAN TISSUE; INFLAMMATION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MAMMARY ARTERY; MICROARRAY ANALYSIS; NUCLEOTIDE SEQUENCE; ORGAN DONOR; PHENOTYPE; POLYMERASE CHAIN REACTION; PROMOTER REGION; TRANSCRIPTION REGULATION; WOUND;

ALLELES; CHROMOSOMES, HUMAN, PAIR 9; CORONARY ARTERY DISEASE; ENDARTERECTOMY, CAROTID; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE FREQUENCY; GENE REGULATORY NETWORKS; GENETIC PREDISPOSITION TO DISEASE; HEART VALVE DISEASES; HUMANS; MALE; MIDDLE AGED; MODELS, GENETIC; MYOCARDIUM; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; REAL-TIME POLYMERASE CHAIN REACTION; RISK FACTORS; TISSUE DONORS;

EID: 84863113857     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0039574     Document Type: Article

References (59)

1. Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ, (2006) Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 367: 1747-1757.
2. Marenberg ME, Risch N, Berkman LF, Floderus B, de Faire U, (1994) Genetic susceptibility to death from coronary heart disease in a study of twins. N Engl J Med 330: 1041-1046.
3. (2007) Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447: 661-678.
4. Helgadottir A, Thorleifsson G, Manolescu A, Gretarsdottir S, Blondal T, et al. (2007) A common variant on chromosome 9p21 affects the risk of myocardial infarction. Science 316: 1491-1493.
5. McPherson R, Pertsemlidis A, Kavaslar N, Stewart A, Roberts R, et al. (2007) A common allele on chromosome 9 associated with coronary heart disease. Science 316: 1488-1491.
6. Samani NJ, Erdmann J, Hall AS, Hengstenberg C, Mangino M, et al. (2007) Genomewide association analysis of coronary artery disease. N Engl J Med 357: 443-453.
7. Abdullah KG, Li L, Shen GQ, Hu Y, Yang Y, et al. (2008) Four SNPS on chromosome 9p21 confer risk to premature, familial CAD and MI in an American Caucasian population (GeneQuest). Ann Hum Genet 72: 654-657.
8. Assimes TL, Knowles JW, Basu A, Iribarren C, Southwick A, et al. (2008) Susceptibility locus for clinical and subclinical coronary artery disease at chromosome 9p21 in the multi-ethnic ADVANCE study. Hum Mol Genet 17: 2320-2328.
9. Broadbent HM, Peden JF, Lorkowski S, Goel A, Ongen H, et al. (2008) Susceptibility to coronary artery disease and diabetes is encoded by distinct, tightly linked SNPs in the ANRIL locus on chromosome 9p. Hum Mol Genet 17: 806-814.
10. Hinohara K, Nakajima T, Takahashi M, Hohda S, Sasaoka T, et al. (2008) Replication of the association between a chromosome 9p21 polymorphism and coronary artery disease in Japanese and Korean populations. J Hum Genet 53: 357-359.
11. Larson MG, Atwood LD, Benjamin EJ, Cupples LA, D'Agostino RB Sr, et al. (2007) Framingham Heart Study 100 K project: genome-wide associations for cardiovascular disease outcomes. BMC Med Genet 8: S5.
12. Schunkert H, Gotz A, Braund P, McGinnis R, Tregouet DA, et al. (2008) Repeated replication and a prospective meta-analysis of the association between chromosome 9p21.3 and coronary artery disease. Circulation 117: 1675-1684.
13. Shen GQ, Li L, Rao S, Abdullah KG, Ban JM, et al. (2008) Four SNPs on chromosome 9p21 in a South Korean population implicate a genetic locus that confers high cross-race risk for development of coronary artery disease. Arterioscler Thromb Vasc Biol 28: 360-365.
14. Shen GQ, Rao S, Martinelli N, Li L, Olivieri O, et al. (2008) Association between four SNPs on chromosome 9p21 and myocardial infarction is replicated in an Italian population. J Hum Genet 53: 144-150.
15. Talmud PJ, Cooper JA, Palmen J, Lovering R, Drenos F, et al. (2008) Chromosome 9p21.3 coronary heart disease locus genotype and prospective risk of CHD in healthy middle-aged men. Clin Chem 54: 467-474.
16. Scott LJ, Mohlke KL, Bonnycastle LL, Willer CJ, Li Y, et al. (2007) A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science 316: 1341-1345.
17. Zeggini E, Weedon MN, Lindgren CM, Frayling TM, Elliott KS, et al. (2007) Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes. Science 316: 1336-1341.
18. Helgadottir A, Thorleifsson G, Magnusson KP, Gretarsdottir S, Steinthorsdottir V, et al. (2008) The same sequence variant on 9p21 associates with myocardial infarction, abdominal aortic aneurysm and intracranial aneurysm. Nat Genet 40: 217-224.
19. Gschwendtner A, Bevan S, Cole JW, Plourde A, Matarin M, et al. (2009) Sequence variants on chromosome 9p21.3 confer risk for atherosclerotic stroke. Ann Neurol 65: 531-539.
20. Matarin M, Brown WM, Singleton A, Hardy JA, Meschia JF, (2008) Whole genome analyses suggest ischemic stroke and heart disease share an association with polymorphisms on chromosome 9p21. Stroke 39: 1586-1589.
21. Bishop DT, Demenais F, Iles MM, Harland M, Taylor JC, et al. (2009) Genome-wide association study identifies three loci associated with melanoma risk. Nat Genet 41: 920-925.
22. Chen J, Li D, Wei C, Sen S, Killary AM, et al. (2007) Aurora-A and p16 polymorphisms contribute to an earlier age at diagnosis of pancreatic cancer in Caucasians. Clin Cancer Res 13: 3100-3104.
23. Debniak T, Gorski B, Huzarski T, Byrski T, Cybulski C, et al. (2005) A common variant of CDKN2A (p16) predisposes to breast cancer. J Med Genet 42: 763-765.
24. Driver KE, Song H, Lesueur F, Ahmed S, Barbosa-Morais NL, et al. (2008) Association of single-nucleotide polymorphisms in the cell cycle genes with breast cancer in the British population. Carcinogenesis 29: 333-341.
25. Gayther SA, Song H, Ramus SJ, Kjaer SK, Whittemore AS, et al. (2007) Tagging single nucleotide polymorphisms in cell cycle control genes and susceptibility to invasive epithelial ovarian cancer. Cancer Res 67: 3027-3035.
26. Healy J, Belanger H, Beaulieu P, Lariviere M, Labuda D, et al. (2007) Promoter SNPs in G1/S checkpoint regulators and their impact on the susceptibility to childhood leukemia. Blood 109: 683-692.
27. Kumar R, Smeds J, Berggren P, Straume O, Rozell BL, et al. (2001) A single nucleotide polymorphism in the 3′untranslated region of the CDKN2A gene is common in sporadic primary melanomas but mutations in the CDKN2B, CDKN2C, CDK4 and p53 genes are rare. Int J Cancer 95: 388-393.
28. Shete S, Hosking FJ, Robertson LB, Dobbins SE, Sanson M, et al. (2009) Genome-wide association study identifies five susceptibility loci for glioma. Nat Genet 41: 899-904.
29. Wrensch M, Jenkins RB, Chang JS, Yeh RF, Xiao Y, et al. (2009) Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility. Nat Genet 41: 905-908.
30. Melzer D, Frayling TM, Murray A, Hurst AJ, Harries LW, et al. (2007) A common variant of the p16(INK4a) genetic region is associated with physical function in older people. Mech Ageing Dev 128: 370-377.
31. Schunkert H, Konig IR, Kathiresan S, Reilly MP, Assimes TL, et al. (2011) Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. Nat Genet 43: 333-338.
32. Brautbar A, Ballantyne CM, Lawson K, Nambi V, Chambless L, et al. (2009) Impact of adding a single allele in the 9p21 locus to traditional risk factors on reclassification of coronary heart disease risk and implications for lipid-modifying therapy in the Atherosclerosis Risk in Communities study. Circ Cardiovasc Genet 2: 279-285.
33. Pasmant E, Laurendeau I, Heron D, Vidaud M, Vidaud D, et al. (2007) Characterization of a germ-line deletion, including the entire INK4/ARF locus, in a melanoma-neural system tumor family: identification of ANRIL, an antisense noncoding RNA whose expression coclusters with ARF. Cancer Res 67: 3963-3969.
34. Cunnington MS, Santibanez Koref M, Mayosi BM, Burn J, Keavney B, (2010) Chromosome 9p21 SNPs Associated with Multiple Disease Phenotypes Correlate with ANRIL Expression. PLoS Genet 6: e1000899.
35. Harismendy O, Notani D, Song X, Rahim NG, Tanasa B, et al. (2011) 9p21 DNA variants associated with coronary artery disease impair interferon-gamma signalling response. Nature 470: 264-268.
36. Burd CE, Jeck WR, Liu Y, Sanoff HK, Wang Z, et al. (2010) Expression of linear and novel circular forms of an INK4/ARF-associated non-coding RNA correlates with atherosclerosis risk. PLoS Genet 6: e1001233.
37. Jarinova O, Stewart AF, Roberts R, Wells G, Lau P, et al. (2009) Functional analysis of the chromosome 9p21.3 coronary artery disease risk locus. Arterioscler Thromb Vasc Biol 29: 1671-1677.
38. Liu Y, Sanoff HK, Cho H, Burd CE, Torrice C, et al. (2009) INK4/ARF transcript expression is associated with chromosome 9p21 variants linked to atherosclerosis. PLoS One 4: e5027.
39. Holdt LM, Beutner F, Scholz M, Gielen S, Gabel G, et al. (2010) ANRIL expression is associated with atherosclerosis risk at chromosome 9p21. Arterioscler Thromb Vasc Biol 30: 620-627.
40. Folkersen L, Kyriakou T, Goel A, Peden J, Malarstig A, et al. (2009) Relationship between CAD risk genotype in the chromosome 9p21 locus and gene expression. Identification of eight new ANRIL splice variants. PLoS One 4: e7677.
41. Yap KL, Li S, Munoz-Cabello AM, Raguz S, Zeng L, et al. (2010) Molecular interplay of the noncoding RNA ANRIL and methylated histone H3 lysine 27 by polycomb CBX7 in transcriptional silencing of INK4a. Mol Cell 38: 662-674.
42. Yu W, Gius D, Onyango P, Muldoon-Jacobs K, Karp J, et al. (2008) Epigenetic silencing of tumour suppressor gene p15 by its antisense RNA. Nature 451: 202-206.
43. Isumi Y, Hirata T, Saitoh H, Miyakawa T, Murakami K, et al. (2011) Transgenic overexpression of USP15 in the heart induces cardiac remodeling in mice. Biochem Biophys Res Commun 405: 216-221.
44. Dimova DK, Dyson NJ, (2005) The E2F transcriptional network: old acquaintances with new faces. Oncogene 24: 2810-2826.
45. Almontashiri N, Fan M, Chen H-H, Teng A, Chen B, et al. (2011) Abstract 15730: Serum Interferon Alpha 21 is a Biomarker of the 9p21.3 Risk Locus for Coronary Artery Disease. American Heart Association Scientific Sessions 2011. Orlando, FL: Circulation.
46. Visel A, Zhu Y, May D, Afzal V, Gong E, et al. (2010) Targeted deletion of the 9p21 non-coding coronary artery disease risk interval in mice. Nature 464: 409-412.
47. Frolov MV, Dyson NJ, (2004) Molecular mechanisms of E2F-dependent activation and pRB-mediated repression. Journal of cell science 117: 2173-2181.
48. Chen M, Capps C, Willerson JT, Zoldhelyi P, (2002) E2F-1 regulates nuclear factor-kappaB activity and cell adhesion: potential antiinflammatory activity of the transcription factor E2F-1. Circulation 106: 2707-2713.
49. Chomczynski P, Sacchi N, (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159.
50. Ellmers LJ, Scott NJ, Piuhola J, Maeda N, Smithies O, et al. (2007) Npr1-regulated gene pathways contributing to cardiac hypertrophy and fibrosis. J Mol Endocrinol 38: 245-257.
51. Folkersen L, van't Hooft F, Chernogubova E, Agardh HE, Hansson GK, et al. (2010) Association of genetic risk variants with expression of proximal genes identifies novel susceptibility genes for cardiovascular disease. Circ Cardiovasc Genet 3: 365-373.
52. Robinson MD, Speed TP, (2007) A comparison of Affymetrix gene expression arrays. BMC Bioinformatics 8: 449.
53. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, et al. (2004) Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 5: R80.
54. Smyth G, (2005) Limma: linear models for microarray data. In: Gentleman R, Carey V, Dudoit S, Irizarry R, Huber W, editors. pp. 397-420 editors. Bioinformatics and Computational Biology Solutions using R and Bioconductor. New York: Springer.
55. Benjamini Y, Hochberg Y, (1995) Controlling the False Discovery Rate- a Practical and Powerful Approach to Multiple Testing. Journal of the Royal Statistical Society Series B-Methodological 57: 289-300.
56. Pilbrow AP, Ellmers LJ, Black MA, Moravec CS, Sweet WE, et al. (2008) Genomic selection of reference genes for real-time PCR in human myocardium. BMC Med Genomics 1: 64.
57. Huang da W, Sherman BT, Lempicki RA, (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nature protocols 4: 44-57.
58. Huang da W, Sherman BT, Lempicki RA, (2009) Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic acids research 37: 1-13.
59. Ho Sui SJ, Mortimer JR, Arenillas DJ, Brumm J, Walsh CJ, et al. (2005) oPOSSUM: identification of over-represented transcription factor binding sites in co-expressed genes. Nucleic Acids Res 33: 3154-3164.